Notification of Allotment of Securities

Capital Change Notice


Section 1: Issuer information
Name of issuer Heartland Group Holdings
Limited
NZX ticker code HGH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZHGHE0007S9
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 2,443,526
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $0.92856675
Nature of the payment (for example, cash or other
consideration)
Consideration satisfied pursuant
to the Dividend Reinvestment
Plan
Amount paid up (if not in full) Fully paid up ordinary shares
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury
Stock, in existence)
1

0.26% of the total number of
fully paid ordinary shares prior to
this issue
For an issue of Convertible Financial Products or Options,
the principal terms of Conversion (for example the
Conversion price and Conversion date and the ranking of the
Financial Product in relation to other Classes of Financial
Product) or the Option (for example, the exercise price and
exercise date)
N/A
Reason for issue/acquisition/redemption and specific
authority for issue/acquisition/redemption/ (the reason for
change must be identified here)
Issue of ordinary shares to those
shareholders that have elected
to participate in the HGH
Dividend Reinvestment Plan,
approved by directors’
resolutions.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the
Class held as Treasury Stock after the
issue/acquisition/redemption.
942,543,367 as ordinary shares
(excluding Treasury Stock)

459,070 Treasury Stock
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Directors’ resolution
Issue of Ordinary Shares under
Listing Rule 4.8.1

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Pursuant to the terms of the
HGH Dividend Reinvestment
Plan Offer Document dated 20
August 2025
Date of issue/acquisition/redemption
2
12/09/2025
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement
Andrew Dixson, Chief Executive
Officer
Contact person for this announcement
Nicola Foley, Head of Corporate
Communications and Investor
Relations
Contact phone number 027 345 6809
Contact email address Nicola.Foley@heartland.co.nz
Date of release through MAP

12/09/2025




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).